GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Twi Biotechnology 6610.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

17.80

-1.66%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−TWD 357.5m

FY2016FY2025

Free cash flow

−TWD 292.9m

FY2016FY2025

Shareholders' equity

TWD 630.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue————TWD 66.4mTWD 1.2mTWD 9.7mTWD 25.8mTWD 75.0m—
Gross profit—−TWD 9.7m−TWD 9.7m−TWD 10.4mTWD 65.5mTWD 203,000TWD 2.4mTWD 4.7mTWD 29.3m—
Research and developmentTWD 324.0mTWD 144.1mTWD 148.4mTWD 74.6mTWD 66.7mTWD 85.0mTWD 97.0mTWD 92.8mTWD 105.9mTWD 98.5m
Operating income−TWD 357.0m−TWD 178.5m−TWD 169.6m−TWD 90.2m−TWD 15.3m−TWD 98.6m−TWD 113.9m−TWD 115.3m−TWD 98.6m−TWD 118.8m
Net income−TWD 357.5m−TWD 164.8m−TWD 170.7m−TWD 76.2m−TWD 15.3m−TWD 101.9m−TWD 111.5m−TWD 112.5m−TWD 104.8m−TWD 118.1m
Diluted earnings per share-4.05-1.77-2.16-1.13-0.22-1.45-1.59-1.78-1.74-1.96

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 723.6mTWD 242.3mTWD 396.9mTWD 234.3mTWD 311.0mTWD 387.0mTWD 429.1mTWD 542.0mTWD 274.5mTWD 354.3m
Cash and short-term investments—TWD 175.6mTWD 323.7mTWD 160.4mTWD 223.1mTWD 212.3mTWD 329.0mTWD 487.1mTWD 219.6mTWD 310.2m
Total liabilitiesTWD 93.1mTWD 66.5mTWD 55.8mTWD 28.4mTWD 32.2mTWD 92.9mTWD 5.2mTWD 34.5mTWD 40.3mTWD 17.6m
Debt—TWD 15.6mTWD 8.0mTWD 2.5mTWD 5.0mTWD 7.5mTWD 2.6m———
Shareholders' equityTWD 630.4mTWD 175.8mTWD 341.0mTWD 205.9mTWD 278.8mTWD 294.1mTWD 396.0mTWD 507.5mTWD 234.2mTWD 336.7m
Shares outstanding88m93m79m67m70m70m70m63m60m60m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 287.0m−TWD 155.4m−TWD 134.2m−TWD 60.2m−TWD 34.5m−TWD 62.6m−TWD 97.8m−TWD 114.7m−TWD 85.0m−TWD 100.6m
Capital spending−TWD 5.9m−TWD 308,000−TWD 134.2m—−TWD 30.2m−TWD 30.0m−TWD 243,000−TWD 2.1m−TWD 5.8m−TWD 1.9m
Free cash flow−TWD 292.9m−TWD 155.7m−TWD 268.4m−TWD 60.2m−TWD 64.7m−TWD 92.6m−TWD 98.1m−TWD 116.9m−TWD 90.8m−TWD 102.5m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
Revenue———————TWD 33.2m
Gross profit−TWD 4.8m−TWD 4.9m−TWD 9.7m−TWD 4.9m———TWD 32.7m
Operating income−TWD 82.3m−TWD 72.1m−TWD 106,380−TWD 169.5m−TWD 43,612−TWD 42,503−TWD 76.1m−TWD 7.6m
Net income−TWD 87.0m−TWD 68.3m−TWD 96.5m−TWD 130.0m−TWD 40.7m−TWD 37.4m−TWD 38.8m−TWD 7.6m
Diluted earnings per share-0.99-0.73-1.04-1.65-0.52-0.55-0.58-0.11
Cash from operations−TWD 67.0m−TWD 63.0m−TWD 91.0m−TWD 97.0m———−TWD 17.0m
Capital spending———−TWD 97.0m———−TWD 15.0m
Free cash flow———−TWD 194.0m———−TWD 32.0m
Total assetsTWD 393.6mTWD 242.3mTWD 299.9mTWD 396.9mTWD 191.1mTWD 234.3m—TWD 311.0m
Cash and short-term investmentsTWD 332.6mTWD 175.6mTWD 230.4mTWD 323.7mTWD 122.4mTWD 160.4m—TWD 223.1m
DebtTWD 5.4mTWD 12.7mTWD 5.3mTWD 4.7mTWD 1.3mTWD 2.5m—TWD 2.5m
Shareholders' equityTWD 268.9mTWD 175.8mTWD 243.6mTWD 341.0mTWD 165.3mTWD 205.9m—TWD 278.8m

Financial ratios

Data as of 18 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin————98.6%16.3%24.4%
Operating margin————-22.9%-8064.8%-1153.3%
Net margin————-23.0%-8174.8%-1154.0%
Return on equity-56.7%-93.7%-50.0%-37.0%-5.5%-34.6%—
Return on assets-49.4%-68.0%-43.0%-32.5%-4.9%-26.3%—
Free cash flow yield-6.9%-3.6%0.0%—-0.1%-1.0%-3.0%
Revenue growth————5228.8%-87.1%—
Earnings growth116.9%-3.4%124.1%398.0%-85.0%-8.7%—
Current ratio2.98x2.93x6.85x6.32x8.48x2.52x—
Debt to equity—0.07x0.01x0.02x0.02x0.02x0.01x
Equity ratio87.1%72.6%85.9%87.9%89.6%76.0%—
Interest coverage-2139.83x-1048.71x-1960.87x-1586.02x-176.87x-5024.35x—
R&D as a share of sales————100.4%6820.9%1003.8%
Buybacks as a share of market value5.0%-17.8%-17.0%4.0%0.0%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Operating income58.2%29.4%11.7%
Net income67.4%28.5%10.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-1.6-3.0-2.4-4.8-26.6-3.8-2.0-4.1-7.1-12.4
Price to sales————6.1307.623.117.810.0—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.